Market Data graphic

Sciences biologiques

Vous êtes ici

Le secteur des sciences biologiques comprend des sociétés dont les activités concernent les produits biopharmaceutiques, la fabrication et la distribution médicale et les produits biologiques.

Grown Rogue International Inc. (CSE: GRIN | OTC: GRUSF) is a craft cannabis company operating in Oregon, Michigan, Minnesota, Maryland, and New Jersey, focused on delighting customers with premium flower and flower-derived products at fair prices. The Company's roots are in Southern Oregon, where it has proven its capabilities in the highly competitive and discerning Oregon market. The Company's passion for quality product and value, combined with a disciplined approach to growth, prioritizes profitability and return on capital without sacrificing quality. The Company's strategy is to pursue capital efficient methods to expand into new markets, bringing craft-quality product at fair prices to more consumers. The Company also continues to make modest investments to improve outdoor craft cultivation capabilities in preparation for eventual interstate commerce. For more information, visit www.grownrogue.com.

Grown Rogue has two classes of equity shares: subordinate voting shares (“SVS”) and multiple voting shares (“MVS”). SVS are publicly traded on the CSE and are entitled to one vote.  MVS are not publicly traded, can convert to SVS at a ratio of 1 MVS to 1,000 SVS, and are entitled to 1,000 votes per MVS.

There are 143,421,865 SVS outstanding and 75,194.941 MVS convertible to 75,194,941 outstanding for a total outstanding SVS of 218,616,806 on an as-converted basis.

Please see Schedule “A” to Grown Rogue’s management information circular dated May 14, 2024 for a further description of the SVS and MVS.

At the forefront of the plant-based revolution, Happy Belly Food Group is focused on offering delicious and functional plant-based food to people in every facet of life. Whether you are already committed to a plant-based lifestyle or you are thinking about it, we want to be part of your journey.

HAVN Life Sciences Inc. is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs and the development of natural health products and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of GMP naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, the company offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.  Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram and Youtube.

Hempsana Holdings Ltd. est une société d'extraction et de purification de dérivés du cannabis et de fabrication de produits finis infusés au cannabis. Elle propose des dérivés de cannabinoïdes pour les canaux de vente médicaux et de vente au détail, des formulations de produits finis et des offres de services pour l'extraction et le post-traitement.

Herbal Dispatch owns and operates leading cannabis e-commerce platforms in both Canada and the United States and is dedicated to providing top quality cannabis to informed consumers at affordable pricing.

Herbal Dispatch's flagship cannabis marketplace, Herbal Dispatch, is a trusted source for exclusive access to small-batch craft cannabis flower and a wide-array of other product formats.

Herbal Dispatch’s common shares trade on the Canadian Securities Exchange under the symbol “HERB”.

HYTN formule, fabrique, commercialise et vend des produits de cannabis haut de gamme. Avec pour mission d'être le principal fournisseur de produits de cannabis cohérents, naturels et délicieux, HYTN concentre ses efforts sur l'identification des opportunités de catégorie et adopte une approche innovante pour offrir des expériences de cannabis élevées à une clientèle exigeante.

IMCC is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMCC is establishing a fully operational, vertically integrated medical cannabis business spearheaded by its distribution arm in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, making it one of the only medical cannabis companies with fully integrated operations in Europe. IMCC intends to leverage IMCC's brand to establish a foothold in emerging medical cannabis markets including Germany, Portugal and Greece.

Les activités de la Société peuvent être décrites comme trois segments d'exploitation distincts liés à l'incorporation dans les produits de la CDB dans leur formulation : (i) la recherche, le développement, le marketing, la distribution et la vente de produits pharmaceutiques de gré à gré de marque InnoCan produits; ii) la recherche et le développement de produits non pharmaceutiques pour des tiers en échange de frais et/ou de redevances; et (iii) la recherche et le développement d'hydrogels contenant des liposomes destinés à l'octroi de licences ou à la vente à des sociétés pharmaceutiques tierces pour la fabrication, la distribution et la vente.

Irwin Naturals Inc. est une société nutraceutique qui distribue des compléments alimentaires à plus de 100 000 détaillants, y compris des détaillants de masse.

Investor Note: In addition to the 2,643,668 Subordinate Voting Shares that are listed and trading, there are (i) 1,066,000 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting Shares of Irwin Naturals Inc. (ii) 18,240 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Multiple Voting Shares of Irwin Naturals Inc.; (iii) 320,000,000 subordinate voting shares reserved for issuance pursuant to the exchange rights attached to the Class B Non-Voting Shares of Irwin Naturals, an indirect, wholly-owned subsidiary of Irwin Naturals Inc.; and (iv) 20,000 subordinate voting share purchase warrants.  The total number of equity shares assuming all are converted or exchanged, as applicable, into the listed class would be 323,747,908.